Cover: Proposed new cost sharing and the costs of Medicare

Proposed new cost sharing and the costs of Medicare

Published 1983

by Joseph P. Newhouse

Purchase Print Copy

 Format Price
Add to Cart Paperback11 pages $20.00

Results from the Health Insurance Study, a controlled trial of cost sharing, are described. More initial cost sharing, as has been proposed for the Medicare program, will reduce the costs of the program at each point in time, but will probably not affect its long-run rate of growth very much. It will shift costs from taxpayers to program beneficiaries. Thus, even with more initial cost sharing, Medicare program costs, if nothing else is done, are likely to grow faster than GNP. The United States could accept these cost increases, in which case the question is how best to finance them. Alternatively, it could try to increase competition or regulation. Competition is likely to produce little short-run effect on Medicare program costs; regulation will have unknown effects on health outcomes.

This report is part of the RAND paper series. The paper was a product of RAND from 1948 to 2003 that captured speeches, memorials, and derivative research, usually prepared on authors' own time and meant to be the scholarly or scientific contribution of individual authors to their professional fields. Papers were less formal than reports and did not require rigorous peer review.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.